{"id":"https://openalex.org/W79941086","doi":null,"title":"A small step towards personalized medicine for non-small cell lung cancer.","display_name":"A small step towards personalized medicine for non-small cell lung cancer.","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W79941086","mag":"79941086","pmid":"https://pubmed.ncbi.nlm.nih.gov/20040275"},"language":"en","primary_location":{"id":"pmid:20040275","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20040275","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discovery medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066717752","display_name":"Tony S.K. Mok","orcid":"https://orcid.org/0000-0002-8251-0551","observed_orcids":["https://orcid.org/0000-0002-8251-0551"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Tony Mok","raw_affiliation_strings":["Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China. tony@clo.cuhk.edu.hk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China. tony@clo.cuhk.edu.hk","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100632072","display_name":"Yi-Long Lung Cancer Wu","orcid":"https://orcid.org/0000-0002-3611-0258","observed_orcids":["https://orcid.org/0000-0002-3611-0258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-Long Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100425624","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-7000-2955","observed_orcids":["https://orcid.org/0000-0002-7000-2955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.8329,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.93126121,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":"43","first_page":"227","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.7570000290870667},{"id":"https://openalex.org/keywords/carboplatin-paclitaxel","display_name":"carboplatin-paclitaxel","score":0.7630000114440918},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.8309999704360962},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7799999713897705},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8589026927947998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7678263783454895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7403261661529541},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7378019690513611},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.703940749168396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7027518153190613},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6718413829803467},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5656291246414185},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5490612387657166},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.5348915457725525},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4962223172187805},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.382174551486969},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2444470226764679},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.21556225419044495},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.11099377274513245},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08988499641418457}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20040275","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20040275","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discovery medicine","raw_type":"Journal Article"},{"id":"mag:79941086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20040275","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108987760","https://openalex.org/W2160313871","https://openalex.org/W2023512205","https://openalex.org/W1840647661","https://openalex.org/W2164710835","https://openalex.org/W2086757994","https://openalex.org/W2085231506","https://openalex.org/W1918002298","https://openalex.org/W2076947484","https://openalex.org/W2496807276"],"abstract_inverted_index":{"Treatment":[0],"outcome":[1],"for":[2,39,146],"advanced-stage":[3],"non-small":[4],"cell":[5],"lung":[6,40],"cancer":[7,24],"(NSCLC)":[8],"is":[9,64,148],"limited":[10],"by":[11,53,130],"empiric":[12],"administration":[13],"of":[14,50,163],"cytotoxic":[15],"chemotherapy.":[16],"Recent":[17],"advances":[18],"in":[19,78,87,108,160],"molecular":[20],"genomics":[21],"have":[22],"revolutionized":[23],"management":[25,162],"and,":[26],"specifically,":[27],"epidermal":[28],"growth":[29],"factor":[30],"receptor":[31],"(EGFR)":[32],"mutation":[33],"has":[34,140],"become":[35,141],"a":[36,65,157],"potent":[37],"biomarker":[38],"cancer,":[41],"which":[42],"predicts":[43],"tumor":[44],"response":[45],"to":[46],"and":[47,134],"prolonged":[48],"duration":[49],"disease":[51],"control":[52],"EGFR":[54,88,109],"tyrosine":[55],"kinase":[56],"inhibitors":[57],"(TKI).":[58],"The":[59,126],"Iressa":[60],"Pan-Asia":[61],"Study":[62],"(IPASS)":[63],"randomized":[66,137],"phase":[67],"III":[68],"study":[69,133],"comparing":[70],"gefitinib":[71,94,119],"(EGFR":[72],"TKI)":[73],"with":[74,82,93,96,115,118],"paclitaxel/carboplatin":[75],"(standard":[76],"chemotherapy)":[77],"Asian":[79],"non-/light":[80],"smokers":[81],"adenocarcinoma.":[83],"Progression-free":[84],"survival":[85],"(PFS)":[86],"mutation-positive":[89],"patients":[90],"was":[91,113],"longer":[92,114],"than":[95,117],"chemotherapy":[97,116],"(hazard":[98],"ratio":[99],"[HR],":[100],"0.48;":[101],"95%":[102,122],"confidence":[103],"interval":[104],"[CI],":[105],"0.36-0.64;":[106],"p<0.0001);":[107],"mutation-negative":[110],"patients,":[111],"PFS":[112],"(HR":[120],"2.85;":[121],"CI":[123],"2.05-3.98;":[124],"p<0.0001).":[125],"findings":[127],"are":[128],"confirmed":[129],"one":[131],"single-arm":[132],"three":[135],"other":[136],"studies.":[138],"It":[139],"clear":[142],"that":[143],"personalized":[144,154],"medicine":[145,155],"NSCLC":[147],"feasible.":[149],"This":[150],"small":[151],"step":[152],"towards":[153],"represents":[156],"paradigm":[158],"shift":[159],"the":[161],"NSCLC.":[164]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}